Search - tctmd.com

Presenter: Emmanouil Brilakis, Claes Held, Bernhard Meier, Frank Cools, Marc Claeys, Jan Cornel, Philip Aylward, Basil Lewis, Douglas Weaver, Gunnar Brandrup- Wognsen, Susanna Stevens, Lars Wallentin, Stefan James

January 31, 2013

Presentation TCT 2013

Double (360mg) Loading Dose Of Ticagrelor In Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Presenter: Dimitrios Alexopoulos, Ioanna Xanthopoulou, Vassilios Gkizas, George Kassimis, Konstantinos Theodoropoulos, Tsigkas Grigorios, Ioannis Chiladakis, Anastasia Damelou, George Hahalis, Periklis Davlouros

January 31, 2013

News Daily News

La Adenosina podría ser el Nexo de Unión entre el Ticagrelor y la Disnea

Caitlin E. Cox

January 09, 2013

News Daily News

Adenosine May Be the Tie That Binds Ticagrelor and Dyspnea

Caitlin E. Cox

January 09, 2013

Presentation

Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans

Presenter: A. Wittfeldt

January 08, 2013

News Daily News

Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico

January 07, 2013

Advertisement

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Prasugrel No es Inferior al Ticagrelor en los cuadros de STEMI, aunque Deben pasar Horas hasta que Ambos Hagan Efecto

Las Imágenes Detectan Lesiones Vasculares secundarias a las Intervenciones de Denervación Renal basadas en Catéter

Imaging Detects Vascular Injury Arising from Catheter-Based Renal Denervation

La Alta Reactividad Plaquetaria se asocia a Más Episodios Adversos tras Intervenciones Endovasculares

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

Accumetrics Obtains CE Mark for Therapeutic Window Claim on the VerifyNow P2Y12 Test

Comparison of Prasugrel and Ticagrelor Loading Doses in STEMI Patients

Conversations in Cardiology: Brief Question re: BMS-DES and DAPT

Una Dosis Baja de Rivaroxaban Reduce los Episodios Trombóticos y Aumenta las Hemorragias tras un STEMI

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Un Documento de la ESC Orienta sobre el Uso Doble de IBP y Antitrombóticos

ESC Position Paper Offers Guidance on Dual PPI and Antithrombotic Use

Effect of Ticagrelor on the Outcomes of Patients With Prior Coronary Artery Bypass Graft Surgery: Insights From The PLATelet inhibition and patient Outcomes (PLATO) trial

Double (360mg) Loading Dose Of Ticagrelor In Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

La Adenosina podría ser el Nexo de Unión entre el Ticagrelor y la Disnea

Adenosine May Be the Tie That Binds Ticagrelor and Dyspnea

Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans

Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content